KHALED A A A ALOBAID

Dr. KHALED A A A ALOBAID

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
IAInaam Al-Obaid
Inaam Al-Obaid
Mohammad Assadullah AsadzadehMohammad Assadullah Asadzadeh
Mohammad Assadullah Asadzadeh
SASuhail Ahmad
Suhail Ahmad
KAKHALED A A A ALOBAID
KHALED A A A ALOBAID
WAWadha Alfouzan
Wadha Alfouzan
LJLeena Joseph
Leena Joseph
Candida auris is an emerging yeast pathogen that has recently caused major outbreaks in healthcare facilities worldwide. Clinical C. auris isolates are usually resistant to fluconazole and readily develop resistance to echinocandins and amphotericin B (AMB) during treatment. We describe here an interesting case of C. auris infection in an immunocompromised patient who had previously received AMB and caspofungin treatment. Subsequently, C. auris was isolated from tracheal (tracheostomy) secretions and twice from urine and all three isolates were susceptible to AMB and micafungin. The patient received a combination therapy with AMB and caspofungin. Although the C. auris was cleared from the urine, the patient subsequently developed breakthrough candidemia and the bloodstream isolate exhibited a reduced susceptibility to micafungin and also showed the presence of a novel (S639T) mutation in hotspot-1 of FKS1. Interestingly, C. auris from the tracheal (tracheostomy) secretions recovered one and four days later exhibited a reduced susceptibility to micafungin and S639Y and S639T mutations in hotspot-1 of FKS1, respectively. Although the treatment was changed to voriconazole, the patient expired. Our case highlights a novel FKS1 mutation and the problems clinicians are facing to treat invasive C. auris infections due to inherent or developing resistance to multiple antifungal drugs and limited antifungal armamentarium.

20 August 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
KAKHALED A A A ALOBAID
KHALED A A A ALOBAID
SASuhail Ahmad
Suhail Ahmad
Mohammad Assadullah AsadzadehMohammad Assadullah Asadzadeh
Mohammad Assadullah Asadzadeh
EMEiman MA Mokaddas
Eiman MA Mokaddas
NSNourah Al Sweih
Nourah Al Sweih
SVSoumya Varghese
Soumya Varghese
The Candida species cause a majority of invasive fungal infections. In this article, we describe the nationwide epidemiology of candidemia in Kuwait in 2018. Yeast bloodstream isolates submitted from all major hospitals and identified by phenotypic MALDI-TOF MS and/or by molecular methods were studied. Susceptibility testing was performed by Etest. Out of 313 bloodstream yeasts, 239 Candida spp. isolates (excluding duplicate isolates) were obtained during 234 candidemic episodes among 223 patients. Mixed-species candidemia and re-infection occurred in 5 and 11 patients, respectively. C. albicans (n = 74), C. parapsilosis (n = 54), C. tropicalis (n = 35), C. auris (n = 33), C. glabrata (n = 32), other Candida spp. (n = 11), and other yeasts (n = 9) caused fungemia. Nearly 50% of patients were in intensive care units. Candida spp. isolates (except C. glabrata) were susceptible to caspofungin and 27% of C. auris were amphotericin B-resistant. Resistance to fluconazole was 100% in C. auris, 17% in C. parapsilosis, 12% in C. glabrata, and 1% in C. albicans. Mortality was 47% for other Candida/yeast infections. Nationwide candidemia incidence in 2018 was 5.29 cases/100,000 inhabitants. Changes in species spectrum, increasing fluconazole resistance in C. parapsilosis, and the emergence of C. auris as a major pathogen in Kuwait are noteworthy findings. The data could be of help in informing decisions regarding planning, in the allocation of resources, and in antimicrobial stewardship.

1 April 2019 in Journal of Medical Mycology
Verified
Journal Article
Closed access
KAKHALED A A A ALOBAID
KHALED A A A ALOBAID
ZKZ. Khan
Z. Khan

29 October 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
MHMohammed Haider
Mohammed Haider
FAFatema Al-Rashed
Fatema Al-Rashed
ZAZahraa Albaqsumi
Zahraa Albaqsumi
KAKHALED A A A ALOBAID
KHALED A A A ALOBAID
RARawan Alqabandi
Rawan Alqabandi
Rasheed AhmadRasheed Ahmad
Rasheed Ahmad
Atherosclerosis is a chronic degenerative disorder characterized by lipid-dense plaques and low-grade inflammation affecting arterial walls. Foamy macrophages are important in the formation of atherosclerotic plaques and the induction of low-grade inflammation. The presence of lipid-laden macrophages has occurred in infections caused by opportunistic pathogens. Candida albicans is the major cause of candidiasis in immunocompromised patients, including those with diabetes mellitus. However, the role played by C. albicans in macrophage foaming and the associated inflammation is poorly understood. We investigated whether C. albicans induces foaming along with inflammation in macrophages and, if so, by which mechanism(s). We incubated THP-1 macrophages with heat-killed C. albicans (HKCA). HKCA-induced lipid accumulation in macrophages along with increased expression of inflammatory markers, including CD11b and CD11c or expression and secretion of IL-1β. HKCA also increased the expression of PPARγ, CD36, and FABP4 in macrophages. Mechanistically, we found that the foamy and inflammatory macrophage phenotype induced by HKCA requires FABP4 because disruption of FABP4 in macrophages either by chemical inhibitor BMS309404 or small interfering RNA (siRNA) abrogated foam cell formation and expression of inflammatory markers CD11b, CD11c, and IL-1β. Furthermore, HKCA-treated macrophages displayed high expression and secretion of MMP-9. Inhibition of FABP4 resulted in suppression of HCKA-induced MMP-9 production. Overall, our results demonstrate that C. albicans induces foam cell formation, inflammation, and MMP-9 expression in macrophages via the upregulation of FABP4, which may constitute a novel therapeutic target for treating C. albicans-induced atherosclerosis.

1 September 2023 in Journal of Medical Mycology
Verified
Journal Article
Closed access
YDYousef Dashti
Yousef Dashti
KAKHALED A A A ALOBAID
KHALED A A A ALOBAID
SAShahad Al-Rashidi
Shahad Al-Rashidi
MDMaryam Dashti
Maryam Dashti
MAMoustafa Hussain AbdulMoneim
Moustafa Hussain AbdulMoneim
KJKarin Meinike Jørgensen
Karin Meinike Jørgensen

8 April 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ZKZiauddin Khan
Ziauddin Khan
SASuhail Ahmad
Suhail Ahmad
LJLeena Joseph
Leena Joseph
KAKHALED A A A ALOBAID
KHALED A A A ALOBAID
Candida glabrata has emerged as an important human pathogen associated with systemic and mucosal infections. Here, we describe isolation of two cholesterol-dependent Candida glabrata strains from a candidemia patient which failed to grow on the media devoid of a cholesterol source.